Is risperidone still under patent?
Risperidone was first developed decades ago and is sold widely as a generic drug, which indicates the original core patents have long since expired in most countries. However, specific patent status can still vary by country and by “what exactly” you mean by patent (the original medicine vs. later formulations, uses, or combinations). Public patent terms are also separate from market “exclusivity” periods that regulators may apply.
What patents might still exist for risperidone?
Even if the original active-ingredient patent has expired, later intellectual property can sometimes remain, such as patents covering:
- Long-acting injectable (LAI) formulations or delivery systems
- Specific salt forms, manufacturing processes, or dosing regimens
- New approved indications or specific therapeutic combinations
Those can create “patches” of protection even after generics enter, depending on the jurisdiction.
What happens if the risperidone patent expired—can generics be made?
When the relevant patents covering the specific product are no longer in force, generic manufacturers can usually pursue regulatory approval and marketing. Patent expiration does not automatically remove regulatory requirements; the generic still must meet drug quality and bioequivalence requirements.
How do I check risperidone patent status for a specific country?
Patent status depends on location and on the product version. To check accurately, you typically need:
- The country (e.g., US, EU, UK, Canada, India)
- The product type (oral tablets vs. long-acting injection)
- The marketing authorization name/brand and strength
Then you search that jurisdiction’s patent database (or a patent aggregator) for filings tied to that exact product.
Can you tell me what “risperidone paten” means in your case?
If you mean one of these, I can tailor the answer:
- “Has the risperidone original patent expired?” (overall yes in most places)
- “Is the long-acting injection still protected?”
- “What is the patent expiry date in the US/EU?”
- “Are there any active patents blocking specific generic versions?”
Reply with your country and whether you mean oral risperidone or a long-acting injection (and the brand name if you have it).